Peroxisome Proliferator-Activated Receptors and their Ligands: Entry Into the Post-Glucocorticoid Era of Skin Treatment?

Author： Weindl Günther  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.14, 2005-01, pp. : 1919-1934

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury

By Paola Rosanna   Cuzzocrea Salvatore  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 375, Iss. 3, 2007-05 ,pp. : 157-175

Springer Publishing Company

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor-γ ligands for the treatment of breast cancer

By Fenner Martin H   Elstner Elena  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 557-568

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor ligands in atherosclerosis

By Viles-Gonzalez Juan F   Choi Brian G   Fuster Valentin   Badimon Juan J  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptors and the Control of Inflammation Update

By  

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 3, 2004-07 ,pp. : 297-298

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes

By Kintscher U.   Goetze S.   Wakino S.   Kim S.   Nagpal S.   Chandraratna R.A.S.   Graf K.   Fleck E.   Hsueh W.A.   Law R.E.  

European Journal of Pharmacology, Vol. 401, Iss. 3, 2000-08 ,pp. : 259-270

Elsevier

Access to resources Recommend Favorite